However, in a study by Tazawa et al., it was reported that there was a modest salutary effect on the A-aDO2 and CT density quantitative measurement but no clinical benefits of inhaled recombinant GM-CSF in autoimmune PAP patients [13]. Here, CSF2 is linked to autoimmune pulmonary alveolar proteinosis.